Age-related remodeling of the immune system leaves older adults increasingly susceptible to sudden infections and cancer, while also promoting chronic, misdirected inflammation and impaired wound repair. These effects help drive a wide spectrum of long-term diseases. Yet despite rapid progress in immunology and gerontology, key mechanistic links—how specific immune-cell programs degrade over time and how that degradation shapes early response decisions—remain incompletely understood.
A major obstacle has been the limited availability of immune-aging models that are both predictive and experimentally tractable. Conventional in vitro systems often fail to capture the tissue context, cellular crosstalk, and microenvironmental cues that govern when and how immune responses ignite. As a result, “aging phenotypes” can be difficult to reproduce across laboratories and difficult to connect to causal pathways.
In a 2026 Nature Aging discussion, Nikolich and colleagues argue that the field needs a shift from descriptive comparisons toward engineered, mechanistically grounded platforms. They propose multidisciplinary strategies spanning immunology, gerontology, and engineering to interrogate immune aging at the point of initiation—when innate sensors, tissue barriers, and early signaling networks collectively determine the trajectory of downstream immunity.
The authors highlight drug delivery technologies as a route to more precise interventions. By tuning where, when, and at what dose immunomodulatory agents act, researchers could better test how age-altered signaling thresholds change the balance between protective responses and harmful inflammation.
They also emphasize extracellular matrix (ECM) and biomaterials, noting that aging reshapes the physical and biochemical scaffold surrounding immune cells. Biomaterials that recapitulate age-associated stiffness, ligand density, and degradation dynamics could reveal how microenvironmental cues reprogram immune recruitment, activation, and effector function.
Microphysiological systems and organoid-like models are presented as complementary engines for causality. These platforms can integrate multiple cell types, enable controlled perturbations, and better mimic tissue architecture than traditional culture formats.
Together, these approaches aim to deliver validated in vitro tools for immune-aging research—tools designed not only to measure differences, but to reproduce them reliably and connect them to specific upstream drivers.
The ultimate ambition is precision diagnostics and therapies that can “reprogram and rejuvenate” immune function in older adults, extending both lifespan and healthspan. By targeting immune-response initiation with engineered models, the field may finally bridge the gap between observational aging biology and interventions that work.
Subject of Research: Aging immune system; immune response initiation models and modulation
Article Title: Bioengineering strategies to interrogate and modulate the aging immune system
Article References: Nikolich, J.Ž., Wolf, M.T., Pompano, R.R. et al. Bioengineering strategies to interrogate and modulate the aging immune system. Nat Aging (2026). https://doi.org/10.1038/s43587-026-01187-y
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s43587-026-01187-y
Tags: bioengineering immune modelsdrug delivery for immune modulationengineered platforms for immune researchimmune cell program degradationimmune response decision-makingimmune system agingimmune-cancer links in agingin vitro models of immune aginginflammation and agingmechanistic study of immune agingmultidisciplinary approaches to immunosenescencetissue microenvironment in immunology
